To hear about similar clinical trials, please enter your email below

Trial Title: Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers

NCT ID: NCT06598020

Condition: Integrative Oncology
Medical Education
Palliative Care

Conditions: Official terms:
Neoplasms

Conditions: Keywords:
Medical education
Integrative oncology
Oncology
Supportive care

Study type: Interventional

Study phase: N/A

Overall status: Active, not recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Behavioral
Intervention name: Supportive Care
Description: Competency-based training purposed to alleviate anxiety relief using a mind-body modality and improve pain with touch modalities (e.g., acupressure)
Arm group label: Enhanced competency curriculum-based training
Arm group label: Standard training arm

Summary: The goal of this study is to learn about the short- and long-term effects of two medical education approaches to teaching integrative oncology (IO) in a multi-disciplinary group of healthcare providers attending a national IO training. The main question it aims to answer is: Does active medical education approach focusing on IO-related skills is associated with better training outcomes compared to clerkship-based observation of IO clinics? Participants (trainees) will answer online survey questions about their knowledge, attitudes, and clinical proficiencies along the training process.

Detailed description: The study is conducted within a multi-centered, prospective, controlled and randomized format, using a mixed quantitative and qualitative methodology. Participants eligible for study inclusion are healthcare providers (HCPs, nurses, physicians, para-medical, or complementary medicine practitioners), age ≥ 18 years enrolling in a structured IO training program. Trainees are randomly allocated to either the Enhanced IO Training arm (Group A) or Standard IO Training arm of the study (Group B). Participants in both study arms undergo 110-hour online section of the IO training course, followed by 170-hour practical training. Those in the Enhanced IO Training arm undergo practical training, based on the five-item competency curriculum adapted from the list of knowledge, skills, and ability-related competencies recommended by the Society for Integrative Oncology. The five-item competency-based curriculum include the following two clinical implementation competencies: - Anxiety relief using a mind-body modality (e.g., breathing, relaxation, guided imagery) - Improving pain with touch modalities (e.g., acupressure, acupuncture, reflexology), including use of acupressure points with established effectiveness in the reduction of cancer pain Participants in the Standard IO training group (Group B) will observe from the side during the IO practitioner-patient interaction. The practical section of the training program will include two mentoring days, the first scheduled at the beginning of the 110-hour theory-based IO training, the second at the conclusion of this training. Participants in both study groups will be exposed during the two mentoring days to between 3-5 clinical IO therapeutic interactions with patients admitted to the oncology center.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Healthcare providers (nurses, physicians, para-medical, or complementary medicine practitioners) who have applied to and been accepted for the integrative oncology training program Exclusion Criteria: - Healthcare providers who were not received a letter of support from the medical administrator stating commitment to allocate at least 5 hours weekly post-training to enable the trainee practicing integrative oncology care in the medical center.

Gender: All

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Lin Medical Center

Address:
City: Haifa
Zip: 30243
Country: Israel

Start date: October 1, 2023

Completion date: March 30, 2026

Lead sponsor:
Agency: Carmel Medical Center
Agency class: Other

Collaborator:
Agency: Advot Fund of Reality Group
Agency class: Other

Collaborator:
Agency: Israel Cancer Association
Agency class: Other

Source: Carmel Medical Center

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06598020

Login to your account

Did you forget your password?